Related references
Note: Only part of the references are listed.Malignant peripheral nerve sheath tumor: pathology and genetics
Khin Thway et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma
Carolyn S. Lee et al.
NATURE GENETICS (2014)
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations
A. I. Velghe et al.
ONCOGENE (2014)
Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation
Ting Tao et al.
CELL RESEARCH (2013)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Walter J. Jessen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Distribution and Ca2+ signalling of fibroblast-like (PDGFRα+) cells in the murine gastric fundus
Salah A. Baker et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
Eric P. Rahrmann et al.
NATURE GENETICS (2013)
Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development
Jimann Shin et al.
DISEASE MODELS & MECHANISMS (2012)
Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies
Sandrine Medves et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
Jason R. Karamchandani et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
D. Gareth R. Evans et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
Federica Toffalini et al.
BLOOD (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Ras-Induced Senescence and its Physiological Relevance in Cancer
T. DiMauro et al.
CURRENT CANCER DRUG TARGETS (2010)
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
Tatsuya Ozawa et al.
GENES & DEVELOPMENT (2010)
Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene
Jeong-Soo Lee et al.
HUMAN MOLECULAR GENETICS (2010)
The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment
Jan Zietsch et al.
PLOS ONE (2010)
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor
Federica Perrone et al.
NEURO-ONCOLOGY (2009)
Sox10: A Pan-Schwannian and melanocytic marker
Daisuke Nonaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
An evolutionarily conserved intronic region controls the spatiotemporal expression of the transcription factor Sox10
James R. Dutton et al.
BMC DEVELOPMENTAL BIOLOGY (2008)
High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization
Kiran K. Mantripragada et al.
CLINICAL CANCER RESEARCH (2008)
Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish
D. M. Langenau et al.
ONCOGENE (2008)
Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB
Mikiko Aoki et al.
LABORATORY INVESTIGATION (2007)
Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity
N Holtkamp et al.
CARCINOGENESIS (2006)
In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation
MJ Riemenschneider et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib
CL Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neurofibromatosis type 1 - a model for nervous system tumour formation?
JB Rubin et al.
NATURE REVIEWS CANCER (2005)
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors
S Berghmans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors
N Holtkamp et al.
ACTA NEUROPATHOLOGICA (2004)
Malignant peripheral nerve sheath tumours in neurofibromatosis type 1:: MRI supports the diagnosis of malignant plexiform neurofibroma
VF Mautner et al.
NEURORADIOLOGY (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
J Cools et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human brain tumor-derived PDGFR-α deletion mutant is transforming
ID Clarke et al.
ONCOGENE (2003)
Neurofibromatosis type 1: A diagnostic mimicker at CT
BJ Fortman et al.
RADIOGRAPHICS (2001)
NF1 tumor suppressor gene function: Narrowing the GAP
K Cichowski et al.
CELL (2001)
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells
GA Mashour et al.
ONCOGENE (2001)
The transcription factor Sox10 is a key regulator of peripheral glial development
S Britsch et al.
GENES & DEVELOPMENT (2001)
Share Paper
